Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Seres Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 148
- +17 vs. Q3 2021
- Shares held
- 77.2M
- −2.35M (−3.0%) vs. Q3 2021
- Total value
- $642.8M
- +$88.3M (+15.9%) vs. Q3 2021
- New holders
- 37
- 47 more added
- Sold out
- 20
- 40 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 123,005 | $1.02M | 0.00% | −108,945−47.0% | Reduced |
| Bank of America Corp | 123,208 | $1.03M | 0.00% | −125,117−50.4% | Reduced |
| Engineers Gate Manager LP | 123,498 | $1.03M | 0.05% | +101,998+474.4% | Added |
| Adage Capital Partners GP, L.L.C. | 125,000 | $1.04M | 0.00% | +125,000 | New |
| Harvard Management Co Inc | 131,847 | $1.10M | 0.10% | 00.0% | Unchanged |
| Toronto Dominion Bank | 139,042 | $1.16M | 0.00% | +139,042 | New |
| Qube Research & Technologies Ltd | 144,717 | $1.21M | 0.01% | +144,717 | New |
| Swiss National Bank | 150,800 | $1.26M | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 156,187 | $1.30M | 0.00% | +74,833+92.0% | Added |
| Putnam Investments LLC | 209,297 | $1.74M | 0.00% | +209,297 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 217,968 | $1.82M | 0.01% | +169,987+354.3% | Added |
| Bank of New York Mellon Corp | 220,619 | $1.84M | 0.00% | −53,531−19.5% | Reduced |
| Nuveen Asset Management, LLC | 240,841 | $1.92M | 0.00% | −265,675−52.5% | Reduced |
| BNP Paribas Arbitrage, SA | 238,302 | $1.99M | 0.00% | +225,775+1,802.3% | Added |
| Two Sigma Advisers, LP | 245,900 | $2.05M | 0.01% | −291,000−54.2% | Reduced |
| Barclays PLC | 261,699 | $2.18M | 0.00% | +213,765+446.0% | Added |
| Citigroup Inc | 266,455 | $2.22M | 0.00% | −56,461−17.5% | Reduced |
| Deutsche Bank AG | 279,979 | $2.33M | 0.00% | +201,437+256.5% | Added |
| Cubist Systematic Strategies, LLC | 287,402 | $2.39M | 0.02% | −30,788−9.7% | Reduced |
| PDT Partners, LLC | 300,661 | $2.50M | 0.19% | −7,363−2.4% | Reduced |
| Kynam Capital Management, LP | 304,901 | $2.54M | 1.36% | +304,901 | New |
| Silverarc Capital Management, LLC | 320,602 | $2.67M | 1.20% | +45,769+16.7% | Added |
| Rafferty Asset Management, LLC | 329,981 | $2.75M | 0.01% | −166,983−33.6% | Reduced |
| Citadel Advisors LLC | 395,732 | $3.30M | 0.00% | +300,526+315.7% | Added |
| HRT Financial LP | 405,995 | $3.38M | 0.02% | +405,995 | New |
| Voloridge Investment Management, LLC | 431,885 | $3.60M | 0.02% | −377,496−46.6% | Reduced |
| Charles Schwab Investment Management Inc | 470,292 | $3.92M | 0.00% | +4,409+0.9% | Added |
| Lion Point Capital, LP | 481,803 | $4.01M | 1.32% | 00.0% | Unchanged |
| Morgan Stanley | 544,717 | $4.54M | 0.00% | −136,718−20.1% | Reduced |
| Soviero Asset Management, LP | 550,000 | $4.58M | 1.08% | +550,000 | New |
| Price T Rowe Associates Inc | 560,564 | $4.67M | 0.00% | −799,959−58.8% | Reduced |
| Susquehanna International Group, LLP | 634,682 | $5.29M | 0.01% | +283,466+80.7% | Added |
| Northern Trust Corp | 738,155 | $6.15M | 0.00% | +56,680+8.3% | Added |
| Renaissance Technologies LLC | 746,500 | $6.22M | 0.01% | +746,500 | New |
| Sumitomo Mitsui Trust Holdings, Inc. | 785,519 | $6.54M | 0.00% | −89,404−10.2% | Reduced |
| Nikko Asset Management Americas, Inc. | 785,519 | $6.57M | 0.03% | −89,404−10.2% | Reduced |
| Ikarian Capital, LLC | 795,903 | $6.63M | 1.90% | +189,349+31.2% | Added |
| Geode Capital Management, LLC | 1,237,362 | $10.3M | 0.00% | +282,018+29.5% | Added |
| Goldman Sachs Group Inc | 1,238,450 | $10.3M | 0.00% | +666,935+116.7% | Added |
| Millennium Management LLC | 1,264,486 | $10.5M | 0.01% | +976,368+338.9% | Added |
| Jacobs Levy Equity Management, Inc | 1,290,297 | $10.7M | 0.07% | +1,290,297 | New |
| Vanguard Group Inc | 4,676,265 | $39.0M | 0.00% | +719,993+18.2% | Added |
| State Street Corp | 4,785,589 | $39.9M | 0.00% | −5,217,802−52.2% | Reduced |
| Janus Henderson Group PLC | 5,055,099 | $42.1M | 0.02% | +716,298+16.5% | Added |
| BlackRock Inc. | 5,862,691 | $48.8M | 0.00% | +19,884+0.3% | Added |
| Federated Hermes, Inc. | 6,914,136 | $57.6M | 0.11% | −267,964−3.7% | Reduced |
| FMR LLC | 13,777,070 | $114.8M | 0.01% | +19,285+0.1% | Added |
| Flagship Pioneering Inc. | 14,378,802 | $119.8M | 1.85% | 00.0% | Unchanged |
| AXA S.A. | 0 | $0 | 0.00% | −281,300−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −217,662−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −200,028−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −165,500−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −145,100−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −68,940−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −63,919−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −41,725−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −40,044−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −36,249−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −35,591−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −12,490−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −5,240−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −3,380−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,403−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −748−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |